Antiviral Drugs Market (By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others; By Type: Branded, Generic; By Application: HIV, Hepatitis, Herpes, Influenza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Antiviral Drugs
1.1. Definition and Scope 
1.1.1. Definition of Antiviral Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Antiviral Drugs Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Antiviral Drugs Market By Type
1.2.3. Antiviral Drugs Market By Drug Class
1.2.4. Antiviral Drugs Market By Application 
1.2.5. Antiviral Drugs Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Antiviral Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Antiviral Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Antiviral Drugs Major Manufacturers in 2019

CHAPTER 5. Antiviral Drugs Market By Type
5.1. Introduction
5.2. Antiviral Drugs Revenue By Type
5.2.1. Antiviral Drugs Revenue (US$ Mn) and Forecast, By Type, 2016-2027
5.2.2. Branded
5.2.2.1. Branded  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Generic
5.2.3.1. Generic  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Antiviral Drugs Market Revenue By Drug Class
6.1. Introduction
6.2. Antiviral Drugs Revenue (US$ Mn) By Drug Class
6.2.1. Antiviral Drugs Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
6.2.2. DNA Polymerase Inhibitors
6.2.2.1. DNA Polymerase Inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Reverse Transcriptase Inhibitors
6.2.3.1. Reverse Transcriptase Inhibitors  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Protease Inhibitors
6.2.4.1. Protease Inhibitors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Neuraminidase Inhibitors
6.2.5.1. Neuraminidase Inhibitors  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Others
6.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Antiviral Drugs Market By Application  
7.1. Introduction
7.2. Antiviral Drugs Revenue (US$ Mn) By Application 
7.2.1. Antiviral Drugs Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
7.2.2. HIV
7.2.2.1. HIV Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Hepatitis
7.2.3.1. Hepatitis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Herpes
7.2.4.1. Herpes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Influenza
7.2.5.1. Influenza Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.6. Others
7.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Antiviral Drugs Market By Country 
8.1. North America Antiviral Drugs Overview
8.2. U.S.
8.2.1. U.S. Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.2. U.S. Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.2.3. U.S. Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Canada
8.3.1. Canada Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.2. Canada Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.3.3. Canada Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. North America PEST Analysis

CHAPTER 9. Europe Antiviral Drugs Market By Country
9.1. Europe Antiviral Drugs Market Overview
9.2. U.K.
9.2.1. U.K. Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.2.2. U.K. Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.2.3. U.K. Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3. Germany
9.3.1. Germany Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.3.2. Germany Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.3.3. Germany Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4. France 
9.4.1. France Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.4.2. France Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.4.3. France Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5. Spain
9.5.1. Spain Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.5.2. Spain Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.5.3. Spain Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.6.2. Rest of Europe Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.6.3. Rest of Europe Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Antiviral Drugs Market By Country
10.1. Asia Pacific Antiviral Drugs Market Overview
10.2. China
10.2.1. China Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2. China Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.2.3. China Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Japan
10.3.1. Japan Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2. Japan Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.3.3. Japan Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. India
10.4.1. India Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2. India Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.4.3. India Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5. Australia
10.5.1. Australia Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.2. Australia Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.5.3. Australia Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.2. South Korea Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.6.3. South Korea Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.2. Rest of Asia-Pacific Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.7.3. Rest of Asia-Pacific Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Antiviral Drugs Market By Country
11.1. Latin America Antiviral Drugs Market Overview
11.2. Brazil
11.2.1. Brazil Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2. Brazil Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.2.3. Brazil Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2. Mexico Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.3.3. Mexico Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2. Rest of Latin America Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 – 2027
11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Antiviral Drugs Market By Country 
12.1. Middle East & Africa Antiviral Drugs Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.2. Saudi Arabia Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.2.3. Saudi Arabia Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3. UAE
12.3.1. UAE Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.2. UAE Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.3.3. UAE Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.2. Rest of Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.4.3. Rest of Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.5. Middle East & Africa PEST Analysis

CHAPTER 13. PLAYER ANALYSIS OF ANTIVIRAL DRUGS
13.1. Antiviral Drugs Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Antiviral Drugs Market

CHAPTER 14. COMPANY PROFILE
14.1. Gilead Sciences 
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Gilead Sciences  2019 Antiviral Drugs Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Manufacturing Plant Footprint Analysis
14.2. F. Hoffmann-La Roche AG
14.3. GlaxoSmithKline plc
14.4. AbbVie
14.5. Merck & Co., Inc.
14.6. Johnson & Johnson Services, Inc.
14.7. Bristol-Myers Squibb Company
14.8. Cipla Inc.
14.9. Aurobindo Pharma
14.10. Dr. Reddy’s Laboratories Ltd. 
14.11. Others